Outcomes After Coronary Computed Tomography Angiography in the Emergency Department A Systematic Review and Meta-Analysis of Randomized, Controlled Trials by Hulten, Edward et al.
Journal of the American College of Cardiology Vol. 61, No. 8, 2013
© 2013 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00Outcomes After Coronary Computed
Tomography Angiography in the Emergency Department
A Systematic Review and Meta-Analysis
of Randomized, Controlled Trials
Edward Hulten, MD, MPH,* Christopher Pickett, MD,† Marcio Sommer Bittencourt, MD,*
Todd C. Villines, MD,† Sara Petrillo, MD,‡ Marcelo F. Di Carli, MD,* Ron Blankstein, MD*
Boston, Massachusetts; and Bethesda and Rockville, Maryland
Objectives The aim of the study was to systematically review and perform a meta-analysis of randomized, controlled trials
of coronary computed tomography angiography (CCTA) versus usual care (UC) triage of acute chest pain in the
emergency department (ED).
Background CCTA allows rapid evaluation of patients presenting to the ED with acute chest pain syndromes; however, the
impact of such testing on patient management and downstream testing has emerged as a concern.
Methods We systematically searched for randomized, controlled trials of CCTA in the ED and performed a meta-analysis
of clinical outcomes.
Results Four randomized, controlled trials were included, with 1,869 patients undergoing CCTA and 1,397 undergoing
UC. There were no deaths and no difference in the incidence of myocardial infarction, post-discharge ED visits, or
rehospitalizations. Four studies reported decreased length of stay with CCTA and 3 reported cost savings; 8.4%
of patients undergoing CCTA versus 6.3% of those receiving UC underwent invasive coronary angiography (ICA),
whereas 4.6% of patients undergoing CCTA versus 2.6% of those receiving UC underwent coronary revasculariza-
tion. The odds ratio of ICA for CCTA patients versus UC patients was 1.36 (95% confidence interval [CI]: 1.03 to
1.80, p  0.030), and for revascularization, it was 1.81 (95% CI: 1.20 to 2.72, p  0.004). The absolute in-
crease in ICA after CCTA was 21 per 1,000 CCTA patients (95% CI: 1.8 to 44.9), and the number needed to scan
was 48. The absolute increase in revascularization after CCTA was 20 per 1,000 patients (95% CI: 5.0 to 41.4);
the number needed to scan was 50. Both percutaneous coronary intervention and coronary artery bypass graft
surgery independently contributed to the significant increase in revascularization.
Conclusions Compared with UC, the use of CCTA in the ED is associated with decreased ED cost and length of stay but
increased ICA and revascularization. (J Am Coll Cardiol 2013;61:880–92) © 2013 by the American Col-
lege of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.11.061Acute chest pain is the second most frequent reason for
patient visits to the emergency department (ED) in the
United States (1); however, only a small minority of those
patients ultimately receive a diagnosis of acute coronary
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accepted November 8, 2012.syndrome (ACS) (2). To improve diagnostic accuracy and
cost-effectiveness, various strategies including chest pain
units, novel cardiac biomarkers, and noninvasive cardiac
imaging have been proposed (3). Recent guidelines have
highlighted that the primary goal of this approach is
exclusion of ACS and other serious conditions rather than
detection of coronary artery disease (CAD) (3).
The routine evaluation of acute chest pain in most centers
in the United States includes admission to a hospital or
See page 893
chest pain unit to rule out ACS with the use of serial
electrocardiography and cardiac biomarkers. In selected
patients, stress testing with or without imaging may be used
for further risk stratification (4). Such an approach may
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February 26, 2013:880–92 CCTA in the ED Meta-Analysisavoid the inadvertent discharge of a patient who has ACS,
but is time-consuming and costly and is associated with a
prolonged length of stay (LOS) (4).
Previous studies demonstrated that coronary computed
tomography angiography (CCTA) is a rapid and accurate
technique to exclude the presence of CAD (5,6). Further-
more, the immediate and future likelihood of cardiac events in
patients with no or minimal CAD is extremely low for patients
with nonacute chest pain (7,8). In light of these favorable test
characteristics, several single-center (9–18) and, more recently,
multicenter (19–21) studies have demonstrated the feasibility,
safety, and accuracy of CCTA in the ED.
Due to the rapidly expanding literature in this field, 3
recent meta-analyses evaluated the diagnostic accuracy of
CCTA in the acute setting (22–24). A major limitation of
these investigations was their reliance, by necessity, on
observational studies due to the limited data published at
that time. Moreover, the majority of these studies did not
include any of the currently available multicenter trials.
Although the data consistently show the high negative
predictive value of CCTA, only recently have sufficient
randomized studies been published to investigate post-test
outcomes and downstream testing.
Therefore, the objective of the present meta-analysis was
to evaluate randomized, controlled trials (RCTs) of ED
triage of acute chest pain and compare CCTA and usual
care (UC) for the incidence of invasive coronary angiogra-
phy (ICA), coronary revascularization, death, nonfatal myo-
cardial infarction (MI), repeat ED evaluations for chest
pain, re-admission to the hospital for ACS, LOS, and cost.
Methods
Literature search. We followed the PRISMA statement
(25). A study protocol is not published but is available on
request. We systematically searched PubMed, EMBASE,
ClinicalTrials.gov, and the Cochrane Central Register of
Controlled Trials for RCTs of CCTA in the ED enrolling
at least 100 patients with at least 1 month of follow-up
post-CCTA and published from January 1, 1996, to July 27,
2012. We used the search terms and corresponding MeSH
headings for “emergency cardiac computed tomography”
limited to adult human RCTs from 1996 through July 27,
2012 (see the Online Appendix for full syntax). We did not
limit by language. We additionally searched the references
of all articles retrieved. One author was contacted and
provided additional data for analysis.
We excluded observational studies and studies that did
not randomize patients with chest pain to a control arm of
UC, which would be provided if CCTA was not available.
We included RCTs that reported clinical outcomes for both
in-hospital and downstream events.
Data extraction. Two authors (E.H. and C.P.) indepen-
dently abstracted data using a standardized data extraction
form including study characteristics (design, inclusion and
exclusion criteria), characteristics of the intervention (at least64-slice computed tomography,
use and timing of cardiac enzymes
relative to CCTA, follow-up du-
ration), patient characteristics (age,
sex, cardiac risk factors, and base-
line Thrombolysis In Myocardial
Infarction risk when available),
and outcomes (death, nonfatal MI,
repeat ED chest pain evaluation,
repeat hospitalization for ACS,
ICA, revascularization by percu-
taneous coronary intervention
[PCI]/coronary artery bypass graft
[CABG], LOS, and cost.
Data synthesis. For the primary
analysis, we evaluated absolute in-
cidence of each clinical outcome.
Outcomes were organized into
2  2 tables and pooled using a
fixed-effects model for the primary
analysis of ICA and revasculariza-
tion by PCI/CABG.
Sensitivity analysis. Examina-
tion of heterogeneity was per-
formed visually using Galbraith
plots and statistically using Q sta-
tistics and I2. The I2 statistic pro-
vides an estimate of the variance
due to heterogeneity rather than chance and is based on the
traditional measure of variance, the Cochrane Q statistic (26).
We performed stratified analysis by follow-up duration, ACS
prevalence, and management of significant stenosis (i.e., if
lesions on CCTA with 70% stenosis must undergo ICA vs.
allowance for a primary team to manage CCTA findings). We
assessed for small study effects by the method of Peters (27).
Quality assessment. Two authors (E.H. and C.P.) inde-
pendently assessed study quality using a scale of 0 to 8 based
on the Jadad criteria for RCT reporting (28). E.H. and C.P.
evaluated studies also using the Cochrane Collaboration’s
tool for assessing risk of bias in randomized trials (29).
Disagreements were resolved by consensus.
Statistical analysis. All statistical analyses were performed
with STATA version 12.1 (StataCorp, College Station, Texas)
using themetan commands. The p values were 2-sided, with an
alpha value of 0.05 considered statistically significant.
Results
Results of the literature search are presented in Figure 1.
Four RCTs of 3,266 patients were included (18–21): 1,869
undergoing CCTA and 1,397 evaluated by UC.
The baseline patient demographic characteristics are
listed in Table 1. The mean age of the population was 51
years. There were 1,547 males (47%). Baseline risk factors
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CCTA in the ED Meta-Analysis February 26, 2013:880–92each study and are shown by study in Table 1. Studies had
similar patient eligibility (Table 2), although the ACRIN-PA
(American College of Radiology Imaging Network/
Pennsylvania Department of Health) trial allowed patients
with cocaine exposure, known previous CAD, and positive
biomarkers. The ROMICAT II (Rule Out Myocardial
Ischemia/Infarction Using Computer Assisted Tomography
II) trial sought to enroll higher risk patients who were
randomized earlier in the triage process.
Absolute incidences of clinical outcomes for each of the
individual studies and the combined incidence stratified by UC
and CCTA with corresponding pooled weighted odds ratio
(OR) are reported in Table 3. For each outcome, events during
the index hospitalization, during follow-up, and for the combined
duration (index hospitalization  follow-up) are displayed.
Death and nonfatal MI. There were no deaths. There
were few MIs, and most occurred during the index hospi-
talization, not allowing for a meaningful pooled analysis of
MI as a safety endpoint, as the type of diagnostic test and
MI were not causally related.
Referral for ICA after CCTA versus UC. The pooled
Figure 1 Results of a Literature Search
ACS  acute coronary syndromes; CCTA  cardiac computed tomography angiograweighted incidence of ICA was 8.4% after CCTA versus d6.3% (p  0.030) after UC. Figure 2 depicts the index
ospitalization and downstream rates of referral for ICA.
he pooled OR of ICA for CCTA versus UC was 1.36
95% confidence interval [CI]: 1.03 to 1.80, p  0.030).
he absolute increase for ICA after CCTA was 21 ICA per
,000 CCTA patients (95% CI: 1.8 to 44.9) for a number
eeded to scan (NNS) of 48 patients for 1 additional ICA.
here was no evidence of heterogeneity by I2 (I2 0%, p
.75) or visual inspection of Galbraith or Labbe plots
Online Fig. 1). Systematically excluding each study from
he analysis did not significantly change the effect size,
lthough removal of studies resulted in a nonsignificant
value due to decreased power (Fig. 3).
oronary revascularization by PCI or CABG after
CTA versus UC. The pooled weighted incidence of
CI/CABG was 4.6% after CCTA versus 2.6% (p 0.004)
fter UC. The absolute increase for PCI/CABG after
CTA was 20 per 1,000 patients (95% CI: 5.4 to 42.2) for
n NNS of 50 CCTA for 1 additional PCI/CABG. Figure 2
epicts the index hospitalization and downstream rates of
CI/CABG. The pooled OR (Fig. 4) comparing these rate
R  emergency room; RCT  randomized, controlled trial; UC  usual care.phy; Eifferences was 1.81 (95% CI: 1.20 to 2.72, p  0.004).
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February 26, 2013:880–92 CCTA in the ED Meta-AnalysisThere was no statistically significant evidence of heteroge-
neity by I2 (I2  0%, p  0.64), although the first study by
oldstein et al. was a visual outlier for revascularization by
albraith plot (Online Fig. 1). Stratified analysis and
eta-regression did not identify a statistically significant
ause of the heterogeneity. Systematically excluding this
utlier and other studies did not change the result (Fig. 3).
oth PCI and CABG independently contributed to the
ignificant increase in revascularization (Fig. 4).
A stratified analysis by protocol recommendation of ICA
or 70% CCTA stenosis showed that the increase in ICA
nd PCI/CABG is consistent also in studies that allow for
rimary team management discretion after CCTA (Fig. 5).
Demographic CharacteristicsTable 1 Demographic Characteristics
Goldstein et al. (18) CT-STAT (1
n SD/% n S
n 197 699
UC, n 98 50 338 4
CCTA, n 99 50 361 5
Age, yrs 50 12 50 1
Male, n 98 50 322 4
BMI, kg/m2 29 5.0 28
Hypertension 75 38 259 3
Hyperlipidemia 70 36 234 3
Diabetes 20 10 48
Family history of premature CAD 82 42 212 3
Current smoking 35 18 157 2
Aspirin in past 7 days 52 26 193 2
Chest pain in past 24 h 139 71 353 5
TIMI risk score 1.29 0.80 1.01
ACS 10 5.1 12
UA 10 5.1 6
MI 0 0 6
No testing 0 0 0
Follow-up, months 6 6
CCTA 70% 11 11 13
ACS  acute coronary syndrome; BMI  body mass index; CAD  coronary artery disease; CCTA
nfarction; SD  standard deviation; TIMI  Thrombolysis In Myocardial Infarction; UC  usual ca
Exclusion Criteria by StudyTable 2 Exclusion Criteria by Study
Study Exclusion Criteria
Goldstein et al. (18) Age 25 yrs, known CAD, Trp, ischemic ECG changes,
BMI 39 kg/m2, unable to undergo contrast CT,
LVEF 45%, 12 h without symptoms
CT-STAT (19) Age 25 yrs, known CAD, Trp, ischemic ECG changes,
BMI 39 kg/m2, unable to undergo contrast CT,
LVEF 45%, 12 h since arrival at ED, 12 h from
symptom onset to ED arrival
ACRIN-PA (21) Age 30 yrs, ischemic ECG changes, TIMI risk score
2, normal CCTA within 1 yr, unable to undergo
contrast CT, other major comorbidity requiring
admission
ROMICAT II (20) Age 40 or 75 yrs, known CAD, Trp, ischemic ECG
changes, BMI 40, unable to undergo contrast CT,
6 h since arrival at ED, cocaine, shock
CAD  coronary artery disease; CT  computed tomography; ECG  electrocardiogram; ED 
mergency department; LVEF  left ventricular ejection fraction; Trp  positive troponin; other
bbreviations as in Table 1.ost-discharge ED visits for recurrent chest pain. The
ooled weighted incidence of post-discharge ED visits was
.2% after CCTA versus 4.5% after UC (p  0.70). The
umber of follow-up ED visits avoided per 1,000 patients
canned with CCTA is 3 (95% CI: 13.1 to 14.5), for an
NS of 359. The pooled OR (Fig. 6, top) comparing these
ncidences was 0.94 (95% CI: 0.67 to 1.31, p  0.70). There
as no statistically significant evidence of heterogeneity by I2
(I2  0%, p  0.68). Stratifying by months of follow-up did
not significantly change the outcome: the OR for 6-month
follow-up was 0.77 (95% CI: 0.297 to 1.99, p  0.6).
Post-discharge hospitalizations for ACS. Post-discharge
hospitalizations were rare. The pooled weighted incidence was
1.5% after CCTA versus 1.3% after UC (p  0.5). The
number of post-discharge hospitalizations increased per 1,000
patients scanned with CCTA is 3 (95% CI: 4.2 to 14.5) for
an NNS of 388. The pooled OR (Fig. 6, bottom) comparing
these incidences was 1.20 (95% CI: 0.67 to 2.2, p  0.54).
There was no statistically significant evidence of heterogeneity
by I2 (I2  0%, p  0.68). When stratified by months of
follow-up, all events occurred in the 2 studies with 1-month
follow-up. There were no events in the 6-month-follow up trials.
LOS and cost assessment. Studies enrolled patients at
different times in their hospital course (e.g., ROMICAT II
6 h vs. other studies 12 h) and reported differing LOSs
(e.g., ED stay or total hospital stay). A pooled analysis was
not considered reasonable due to this clinical heterogeneity.
All studies reported a significant reduction in LOS in the
CCTA group. Likewise, studies included differing cost
ACRIN-PA (21) ROMICAT II (20) Pooled
n SD/% n SD/% n SD/%
1,370 1,000 3,266
462 34 499 50 1,397 43
908 66 501 50 1,869 57
49 9.0 54 8.0 51 9.1
645 47 531 53 1,596 49
29 5.1 29 5.0
695 51 541 54 1,570 48
367 27 454 45 1,125 34
194 14 173 17 435 13
394 29 271 27 959 29
447 33 492 49 1,131 35
245 27
492 55
1.06 0.8
48 3.5 75 7.5 145 4.4
35 2.6 52 5.2 103 3.2
13 0.9 23 2.3 42 1.3
167 12.2 118 11.8 285 12.1
1 1
28 3.1 52 4.2
nary computed tomography angiography; ICA  invasive coronary angiography; MI  myocardial
unstable angina.9)
D/%
8
2
0
6
5.0
7
3
6.9
0
2
8
1
0.85
1.7
0.9
0.9
0
3.6components, defined costs differently, and included differing
Death, Nonfatal Myocardial Infarction, and Coronary Revascularization by PCI or CABG Occuring During Index Hospitalization, Post-Discharge, or CombinedTable 3 Death, Nonfatal Myocardial Infarction, and Coronary Revascularization by PCI or CABG Occuring During Index Hospitalization, Post-Discharge, or Combined
Goldstein et al. CT-STAT ACRIN-PA ROMICAT II POOLED
Pooled Weighted
Odds Ratio
(Range) p Value
UC CCTA UC CCTA UC CCTA UC CCTA UC CCTA
n  98 n  99 n  338 n  361 n  462 n  908 n  499 n  501 n  1,397 n  1,869
n % n % n % n % n % n % n % n % n % n %
Combined
Death 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 N/A
MI 0 0.0 0 0.0 5 1.5 1 0.3 5 1.1 10 1.1 19 3.8 9 1.8 29 2.1 20 1.1 0.54 (0.30–0.97) 0.038
ICA 7 7.1 12 12 22 6.5 26 7.2 19 4.1 45 5.0 40 8.0 59 12 88 6.3 142 7.6 1.36 (1.03–1.80) 0.030
Revasc 1 1.0 6 6.1 8 2.4 14 3.9 6 1.3 24 2.6 21 4.2 32 6.4 36 2.6 76 4.1 1.81 (1.21–2.71) 0.004
PCI 1 1.0 4 4.0 8 2.4 10 2.8 6 1.3 21 2.3 17 3.4 27 5.4 32 2.3 62 3.3 1.62 (1.05–2.52) 0.030
CABG 0 0.0 2 2.0 0 0.0 4 1.1 0 0.0 3 0.3 4 0.8 5 1.0 4 0.3 14 0.7 2.51 (0.94–6.74) 0.068
Index
Death 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 N/A
MI 0 0.0 0 0.0 5 1.5 1 0.3 4 0.9 9 1.0 15 3.0 8 1.6 24 1.7 18 1.0 0.58 (0.31–1.10) 0.096
ICA 3 3.1 11 11 21 6.2 24 6.6 18 3.9 37 4.1 36 7.2 54 11 78 5.6 126 6.7 1.36 (1.02–1.83) 0.038
Revasc 1 1.0 5 5.1 8 2.4 13 3.6 4 0.9 23 2.5 18 3.6 29 5.8 31 2.2 70 3.7 1.95 (1.26–3.01) 0.003
PCI 1 1.0 3 3.0 8 2.4 9 2.5 4 0.9 20 2.2 14 2.8 24 4.8 27 1.9 56 3.0 1.75 (1.09–2.80) 0.021
CABG 0 0.0 2 2.0 0 0.0 4 1.1 0 0.0 3 0.3 4 0.8 5 1.0 4 0.3 14 0.7 2.51 (0.94–6.74) 0.068
Post-discharge
Death 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 N/A
MI 0 0.0 0 0.0 0 0.0 0 0.0 1 0.2 1 0.1 4 0.8 1 0.2 5 0.4 2 0.1 0.31 (0.058–1.69) 0.18
ICA 4 4.1 1 1.0 1 0.3 2 0.6 1 0.2 8 0.9 4 0.8 5 1.0 10 0.7 16 0.9 1.29 (0.57–2.92) 0.55
Revasc 0 0.0 1 1.0 0 0.0 1 0.3 2 0.4 1 0.1 3 0.6 3 0.6 5 0.4 6 0.3 0.99 (0.34–2.91) 0.99
PCI 0 0.0 1 1.0 0 0.0 1 0.3 2 0.4 1 0.1 3 0.6 3 0.6 5 0.4 6 0.3 0.99 (0.34–2.91) 0.99
CABG 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 N/A
ER 6 6.1 6 6.1 4 1.2 2 0.6 34 7.4 71 7.8 19 3.8 14 2.8 63 4.5 93 5.0 0.94 (0.67–1.31) 0.70
Admit 0 0 0 0 0 0 0 0 11 2.4 28 3.1 7 1.4 7 1.4 18 1.3 35 1.9 1.20 (0.67–2.16) 0.54
Absolute incidences are reported and differ slightly from pooled weighted incidences in Figure 4.
CABG coronary artery bypass graft surgery; ICA invasive coronary angiography; MImyocardial infarction; N/A not available; PCI percutaneous coronary intervention; Revasc coronary revascularization by PCI or CABG; other abbreviations as in Tables 1 and 2.
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February 26, 2013:880–92 CCTA in the ED Meta-Analysisdurations. Similar to the length of stay outcome, a pooled
analysis of cost was also not performed due to clinical
heterogeneity. Three studies reported cost savings in the
CCTA group, and 1 reported no difference. LOS and costs
are summarized in Table 4.
Assessment of quality of reporting and risk of bias. As-
essment of reporting quality and risk for bias are presented
n Online Table 1. All studies were rated as high quality
median Jadad score5 of 8). Due to the impracticability of
linding imaging tests, no study used a double-blinded
Figure 2 Invasive Angiography and Coronary Revascularization
Stratified bar graph of index hospitalization and post-discharge invasive coronary a
artery bypass graft surgery (bottom). Pooled weighted incidences are reported and
in Table 3. DC  discharge; other abbreviations as in Figure 1.odel that would be considered the gold-standard experi-mental design; patients and investigators were not blinded
to assignment of CCTA or UC. Blinding to study group
was generally performed during event adjudication. CCTA
studies were read by investigators blinded to patient history
or after anonymization in a blinded core laboratory. No
blinded assessment or core laboratory interpretation of UC
was reported. Using the Cochrane tool for risk of bias, the
Goldstein et al. and CT-STAT (Coronary Computed
Tomographic Angiography for Systematic Triage of Acute
Chest Pain Patients to Treatment) trials (18,19) were also
CCTA or UC
aphy (top) and revascularization by percutaneous coronary intervention/coronary
slightly due to weighting of meta-analysis from the absolute incidences shownAfter
ngiogr
differconsidered to have an “unclear” risk of “other problems” that
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CCTA in the ED Meta-Analysis February 26, 2013:880–92could lead to potential bias due to the treatment recommen-
dation of immediate ICA for those with 70% CCTA
stenosis. This was not concluded to be “high” risk of bias
because an independent primary team would likely perform
ICA for those with 70% CCTA stenosis.
mall study effects. There was no statistical evidence of
mall study effects (publication bias) for the primary analysis
Figure 3 Assessment for Influence of Individual Studies
Systematic exclusion of each study (black dots; 95% confidence interval represen
(ICA) (left: odds ratio of 1.36 shown as dark blue line; 95% confidence interval [1
onary intervention/coronary artery bypass graft surgery (right: odds ratio of 1.81 s
lines) Although the Goldstein et al. study had the highest percutaneous coronary i
it did not significantly affect the pooled estimate. Removal of trials reduced power
Figure 4 OR for ICA and Revascularization by PCI/CABG
Pooled weighted incidences are reported and differ slightly due to weighting of me
bypass graft surgery; CI  confidence interval; OR  odds ratio; PCI  percutaneoby the Peters test (p  0.53 for ICA; p  0.14 for
CI/CABG).
iscussion
here are several important findings in this first meta-
nalysis of RCT evaluating the impact of CCTA versus
error bars) did not affect the pooled estimates for invasive coronary angiography
1.80] represented by dashed lines) or the pooled estimate for percutaneous cor-
as dark blue line; 95% confidence interval [1.20 to 2.72] represented by dashed
ntion/coronary artery bypass graft surgery rate because of its small sample size,
nificant difference in ICA, but with a similar odds ratio effect size.
lysis from the absolute incidences shown in Table 3. CABG  coronary artery
ronary intervention; other abbreviations as in Figures 1 and 3.ted by
.03 to
hown
nterve
for sigta-ana
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February 26, 2013:880–92 CCTA in the ED Meta-AnalysisUC in the ED. First, the use of CCTA in low- to
intermediate-risk patients presenting to the ED with
Figure 5 Stratified Analysis of ICA and PCI/CABG According to
Although a strategy of encouraging ICA for any CCTA lesion 70% may increase IC
studies that allow for primary team management discretion after CCTA. Pooled we
in Table 3. Abbreviations as in Figures 1, 3, and 4.chest pain is safe. Indeed, the rate of death, MI, returnED visits, and recurrent hospitalization for cardiovascular
causes was similar between patients evaluated with
agement Strategy After CCTA
consequently PCI/CABG, the increase in ICA and PCI/CABG is consistent also in
incidences are reported and differ slightly from the absolute incidences shownMan
A and
ightedCCTA versus UC. Second, although the definitions used
888 Hulten et al. JACC Vol. 61, No. 8, 2013
CCTA in the ED Meta-Analysis February 26, 2013:880–92for calculating LOS in each study differed and a pooled
analysis was not possible, the average LOS reported in
each study was consistently reduced in patients undergo-
ing CCTA compared with those in the UC arm. Third,
the use of CCTA in the ED significantly increased the
downstream ICA and revascularization (PCI/CABG)
incidence by 2% compared with the UC group. We found
that there was 1 additional ICA for every 48 patients and
1 additional revascularization for every 50 patients eval-
uated with CCTA. However, the present analysis is not
suitable for determining whether these results are due to
Figure 6 OR for the Incidence of Post-discharge Visits to the E
and Re-Admission for ACS After Discharge
Pooled weighted incidences are reported and differ slightly from the absolute incidoveruse of ICA and PCI/CABG in the CCTA group orunderuse in the UC group. In addition, a variety of
factors influence the decision to pursue ICA after CCTA,
including clinical judgment; technical quality of the
CCTA; anatomic details regarding the presence, loca-
tion, and severity of CAD; and experience and expertise
of the readers (and end users) of the CCTA examination,
none of which could be adequately evaluated by our
analysis.
Due to many recent technical advances, CCTA has
evolved into a powerful test that offers the ability to rapidly
and accurately evaluate patients presenting to the ED with
ency Department for Recurrent Chest Pain
on Table 3. Abbreviations as in Figures 1 and 4.merg
encessuspected ACS. A major attribute of this test is that the
as
p
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February 26, 2013:880–92 CCTA in the ED Meta-Analysisabsence of CAD on CCTA not only rules out the presence
of ACS but also conveys an excellent prognosis, at least in
patients with known or suspected stable CAD (30). Indeed,
the use of CCTA among patients with negative initial
biomarkers and electrocardiography is already included in
the algorithm of acute chest pain evaluation in numerous
EDs, a strategy that is supported by the current appropriate
use criteria (31) and American College of Cardiology
guidelines for unstable angina (32). Further supporting
these documents, 3 of the 4 RCTs included in our study
reported ED cost savings in the CCTA group compared
with UC, although more data on the impact on downstream
testing are needed because other studies in different patient
populations suggest that CCTA may result in increased
downstream testing and procedures (33).
Because ICA, PCI, and CABG are procedures that
profoundly affect the cost of CAD care and in light of data
that coronary revascularization procedures are not always
beneficial (34,35), the pivotal question is whether their
increase after CCTA represents an overuse of ICA and
PCI/CABG after CCTA or an underuse in patients under-
going UC. Clinical outcomes such as death and MI were no
different, but these studies were not designed to test for such
a difference. Much larger studies would need to be per-
formed to detect differences in clinical outcomes, given the
(by design) low-risk nature of this population. In addition,
longer term follow-up may identify other differences in
downstream testing between CCTA and UC. For instance,
it is not clear how physicians who evaluate patients with
previously normal findings on CCTA or myocardial perfu-
sion imaging will react when such a patient returns to the
ED with chest pain. Will the higher negative predictive
value of CCTA result in less downstream testing? On the
other hand, previously abnormal findings on CCTA might
lower the threshold for further testing and could increase
LOS and Cost Outcomes by StudyTable 4 LOS and Cost Outcomes by Study
Goldstein et al. (18) CT-STAT (19
Primary outcome Safety, diagnostic efficiency Time to diagnos
LOS definition Time to diagnosis Time to diagnos
UC LOS, h 15.0 (7.3–20.2) 6.2 (4.2–19.
CCTA LOS, h 3.4 (2.3–14.8) 2.9 (2.1–4.0
UC-CCTA LOS, h 11.6* 3.4*
Reduction, % 77.3* 54.8*
Cost Definition ED Cost ED Co
UC cost, US$ 1,872 (1,727–2,069) 3,458 (2,90
CCTA cost, US$ 1,586 (1,413–2,059) 2,137 (1,66
UC-CCTA cost, US$ 286* 1,321
Reduction, % 15.3* 38
Values are mean (SD) or median (interquartile range). Three studies evaluated time to diagnosis,
CCTA strategy reduced by 25% to 27%. Three studies reported ED cost, which a CCTA strategy re
reduction in ED cost due to faster time to diagnosis was offset by the downstream index hospital c
patients with available cost data from 5 of 9 sites in the study. *p  0.05.
LOS  length of stay; other abbreviations as in Tables 1 to 3.the use of stress tests or ICA in this group. rThere are several principles related to effective use of
cardiac testing in the ED that are important to acknowl-
edge. First, not all patients presenting with acute chest pain
require any testing and among those who do need further
testing, CCTA is not an appropriate study for “all comers”:
in very low risk populations, the use of CCTA will unnec-
essarily increase testing, radiation exposure, and down-
stream procedures because many of these patients could be
safely triaged with no testing (36% of UC in ACRIN-PA,
22% in ROMICAT II) or exercise treadmill testing alone
(20,36,37). On the other hand, in high-risk populations, use
of CCTA may be associated with increased downstream
testing due to the presence of lesions with uncertain
hemodynamic significance (33). Second, even among low-
to intermediate-risk individuals, all patients should not by
default undergo CCTA, but rather should be triaged via a
system that incorporates clinical and patient data together
with an understanding of all available testing options in a
given center to select the optimal testing strategy for a given
patient. Third, not all patients with 50% stenosis on
CCTA ought to undergo ICA, despite this recently being
considered to represent appropriate use. Physiological as-
sessment remains useful in many cases before ICA, whether
by nuclear perfusion imaging (38), stress echocardiography,
or potentially in the future stress computed tomography
perfusion (39). Other measures that may reduce ICA and
PCI/CABG include techniques to improve the specificity of
CCTA to identify hemodynamically significant lesions such
as evaluation of rest myocardial perfusion (40), incorpora-
tion of flow hemodynamic modeling such as shear stress
(41) or computed tomography fractional flow reserve (42),
nd evaluation of transarterial gradients (43,44).
There are several important considerations regarding the
tudies included in our analysis. First, the majority of
atients included in the analysis were at low to moderate
ACRIN-PA (21) ROMICAT II (20)
Safety Hospital LOS
Hospital duration Time to diagnosis Hospital duration
24.8 18.7 (11.8) 30.8 (28.0)
18 10.4 (12.6) 23.2 (37.0)
6.8* 8.3* 7.6*
27.4* 44.3* 24.7*
N/A ED Cost Total Hospital
7) N/A 2,566 (1,323) 3,874 (5,298)
7) N/A 2,101 (1,070) 4,026 (6,792)
N/A 465* 152
N/A 18.1* 3.9
CCTA triage strategy reduced by 44% to 77%. Two studies evaluated total hospital LOS, which a
by 15% to 38%. One study reported total hospital cost, which was not significantly different. The
igher ICA and PCI/CABG in the ROMICAT II study. ROMICAT II analyzed a subgroup of 649/1,000)
is
is
0)
)
st
0–4,29
0–3,07
*
.2*
which a
duced
ost of hisk of ACS with normal biomarkers and nondiagnostic or
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studies that reported the Thrombolysis In Myocardial
Infarction risk score, a mean of 1.29 and 1.01 was observed
(Table 1). Accordingly, the overall prevalence of ACS was
low across all studies, with ROMICAT II having the
highest at 8%. Therefore, the current results cannot be
extrapolated to higher risk patients. Nevertheless, low-risk
chest pain remains a far more common presentation in the
ED and is associated with substantial costs.
Second, the evaluation according to UC was not similar
in all studies. In the CT-STAT (19) and in Goldstein et al.
(18), the UC arm included routine myocardial perfusion
imaging, whereas in the ROMICAT II (20) and
ACRIN-PA (21), the use and type of testing were per-
formed at the physicians’ discretion. Accordingly, the last 2
studies had a lower rate of stress testing because some
patients were discharged without any testing.
Third, the protocol after CCTA was not similar in all
studies. Both studies by Goldstein et al. (18) had a pre-
defined protocol that required further testing (myocardial
perfusion imaging in most cases) following all intermediate
lesions and also required that all severe lesions (70%
stenosis) underwent direct ICA and revascularization if
appropriate. The ACRIN-PA and ROMICAT II did not
include a recommendation for myocardial perfusion imag-
ing, ICA, or other downstream testing in the CCTA arm.
Although excess ICA could have resulted from studies using
a protocol that recommended the use of ICA for 70%
CCTA stenosis, a stratified analysis by protocol recom-
mended ICA for severe lesions (Goldstein et al. [18],
CT-STAT [19]) did not have a higher incidence of ICA
post-CCTA compared with studies (ACRIN-PA, ROMI-
CAT II) without such a requirement (Fig. 5).
Study limitations. First, the studies have slightly differen-
tial follow-up (2 papers limited to 1 month post-discharge
and 2 papers at 6 months). However, as shown, the
overwhelming majority of events (89%, Table 3) occurred
during the index hospitalization. Nevertheless, despite the
low event rate in these overall low-risk patients at follow-up,
it is possible that with additional time a divergence in repeat
ED visits and re-admissions for ACS will occur. Although
our study included the largest sample size of any study to
date evaluating the use of CCTA in the ED (1,869 patients
in the CCTA group and 1,397 in the UC group), it
nevertheless remains underpowered to detect clinical differ-
ences in the safety endpoint of MI and death, which are rare
in these patient groups. Second, although the ROMICAT
II trial included centers without specific experience in
CCTA use in the ED, the pooled analysis is likely affected
by an expert center bias because most hospitals included
have imaging expertise. The use of CCTA in centers with
less expertise could potentially lead to increased false-
positive and false-negative CCTA findings, although this
hypothesis has not been adequately studied and the public
health consequences of widespread use of CCTA in com-
munity EDs are not known. Finally, although each studydesign is randomized, it is important to note that allocation
to UC or CCTA cannot be concealed and that CCTA
findings were not blinded to patients and treating clinicians.
Thus, CCTA findings may influence the likelihood of
downstream ICA and revascularization (verification bias).
However, test findings in the UC group may also influence
downstream ICA and revascularization; thus, this verifica-
tion bias should be considered separately from our finding
that ICA rates were higher among those randomized to
CCTA. Thus, for a randomized comparison of 2 diagnostic
triage strategies, differences in these downstream rates are
likely due to differences inherent to each strategy that
should be considered when deciding how to triage such
patients.
Conclusions
CCTA in the ED has safety comparable to that of UC
evaluation and reduces ED cost and LOS, which may offer
relief for the problem of ED overcrowding, but is associated
with a 2% increased incidence of ICA and a similar 2%
increased incidence of revascularization. Whether this in-
creased rate of invasive procedures leads to improved patient
outcomes or decreases the need for future testing is un-
known. Finally, our findings highlight the importance of
measuring in-hospital and downstream ICA and revascu-
larization rates and including such endpoints when design-
ing comparative effectiveness and cost-effectiveness studies.
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